Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

October 23, 2023

Study Completion Date

January 31, 2024

Conditions

Shoulder Impingement Syndrome

Interventions

BIOLOGICAL

LAENNEC

Subacromial spatial administration

OTHER

0.9% normal saline

Subacromial spatial administration

Trial Locations (3)

Keimyung University Dongsan Hospital, Daegu

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong

Chung-Ang University Hospital, Seoul

All Listed Sponsors

collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

lead

Green Cross Wellbeing

INDUSTRY